InvestorsHub Logo
Followers 36
Posts 2833
Boards Moderated 0
Alias Born 10/02/2012

Re: joboggi post# 108125

Thursday, 08/28/2014 6:31:25 AM

Thursday, August 28, 2014 6:31:25 AM

Post# of 130501
Following on that thought, the BBs are converging rapidly. So that is a good thing. So, while the PPS direction has not declared itself, it is slightly more favorable given that the pps which is holding, the MACD and the converging BBs. ( When they are that far apart, the pps rarely moves far even if you wish upon a star and pray real hard. )

On the negative side, the pps remains below the 50 day MA.

For those who keep wondering about my opinion on the company, I am sure that it has horrible management, however it has one excellent product in MANF, which if it does not actually make it to the clinic will most certainly attract investment dollars. IF they complete the p 16 deal, then they will have two interesting compounds. NOW, if I were Dr A, I would make a deal with Pharma and not a small biotech with no money like AMBS, so we will have to see about that. However, if they do not finalize P16 they have MANF.

Within that framework, the PPS will go up and down, and so, when I am materially incorrect about my predictions about the compounds or the pps then let me know, but so far, I've hit every one of the marks. And that is what it is all about.


The truth is incontrovertible. Malice may attack it, ignorance may deride it, but in the end, there it is.
Winston Churchill